Catalogo dei prodotti della ricerca

BILIOTTI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.295
AS - Asia 1.767
EU - Europa 1.214
SA - Sud America 212
AF - Africa 98
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.232
SG - Singapore 666
IT - Italia 430
CN - Cina 273
VN - Vietnam 255
HK - Hong Kong 232
DE - Germania 173
BR - Brasile 156
IN - India 153
FI - Finlandia 136
SE - Svezia 122
FR - Francia 56
GB - Regno Unito 45
UA - Ucraina 41
RU - Federazione Russa 40
CA - Canada 39
AT - Austria 37
BD - Bangladesh 33
JP - Giappone 31
ZA - Sudafrica 30
IE - Irlanda 24
TG - Togo 23
AR - Argentina 22
RO - Romania 22
NL - Olanda 19
ID - Indonesia 17
BG - Bulgaria 16
IQ - Iraq 14
MX - Messico 12
UZ - Uzbekistan 11
EC - Ecuador 10
PK - Pakistan 10
ES - Italia 9
MA - Marocco 9
PL - Polonia 9
TR - Turchia 9
MY - Malesia 8
KE - Kenya 7
SA - Arabia Saudita 7
BE - Belgio 6
BJ - Benin 6
CI - Costa d'Avorio 6
EG - Egitto 6
PH - Filippine 6
CL - Cile 5
KR - Corea 5
PE - Perù 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
CO - Colombia 4
MK - Macedonia 4
NP - Nepal 4
RS - Serbia 4
TW - Taiwan 4
AL - Albania 3
BZ - Belize 3
CZ - Repubblica Ceca 3
IL - Israele 3
JO - Giordania 3
LB - Libano 3
UY - Uruguay 3
AU - Australia 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
LT - Lituania 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 6.588
Salva come PNG Salva come JPEG
Città #
Ashburn 379
Fairfield 371
Singapore 356
Hong Kong 210
San Jose 198
Woodbridge 184
Chandler 170
Seattle 129
Houston 121
Wilmington 116
Ann Arbor 112
Rome 111
Cambridge 101
Los Angeles 78
Helsinki 76
Ho Chi Minh City 70
Santa Clara 70
Buffalo 66
Hanoi 64
Beijing 60
Munich 59
Princeton 49
Dearborn 43
San Paolo di Civitate 41
New York 39
Frankfurt am Main 36
Bremen 35
Hillsboro 34
Lauterbourg 33
Millbury 33
Plano 32
Vienna 31
Lawrence 30
Turku 30
Dallas 29
Fremont 29
San Diego 27
Milan 25
Dublin 24
Hefei 24
The Dalles 24
Cosenza 23
Council Bluffs 23
Lomé 23
Johannesburg 22
Tokyo 22
San Mateo 20
Boston 16
Andover 15
Sofia 15
Haiphong 14
Chicago 13
Redondo Beach 13
São Paulo 13
Jakarta 12
Bengaluru 11
Bologna 11
Tashkent 11
Amsterdam 10
Da Nang 10
Falkenstein 10
Jacksonville 10
Moscow 10
Nuremberg 10
Phoenix 10
Guangzhou 9
Orem 9
Casablanca 8
Falls Church 8
Montreal 8
Rio de Janeiro 8
San Francisco 8
Toronto 8
Biên Hòa 7
Lappeenranta 7
Nairobi 7
Naples 7
Norwalk 7
Abidjan 6
Baie-D'Urfe 6
Belo Horizonte 6
Brooklyn 6
Clementon 6
Fasano 6
Federal 6
Osaka 6
Salt Lake City 6
Altofonte 5
Baghdad 5
Brussels 5
Changsha 5
Des Moines 5
Dhaka 5
Jinan 5
Lima 5
Warsaw 5
Atlanta 4
Austin 4
Baku 4
Boardman 4
Totale 4.312
Salva come PNG Salva come JPEG
Nome #
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events 268
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 228
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia 219
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 217
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 213
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin 200
Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia 186
Encephalopathy in a patient with loiasis treated with albendazole: a case report 182
Platelet activation is associated with myocardial infarction in patients with pneumonia 180
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major 168
Vitamin D deficiency and health-related quality of life in chronic hepatitis C 167
Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease 158
Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: First case report 157
Severe diarrhoea due to Cystoisospora belli infection in a Good syndrome patient 154
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV child-A cirrhosis 154
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy 149
Anti-HBs seroconversion during treatment with entecavir in a patient with chronic hepatitis B virus infection on hemodialysis 149
Renal involvement in HCV related cirrhosis evidenced as glomerular and tubular derangement 148
HCV cirrhotic patients treated with direct acting antivirals: detection of tubular dysfunction and resolution after viral clearance 147
Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence 144
Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization 144
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 139
IL28B Gene Polymorphisms and US Liver Fatty Changes in Patients Who Spontaneously Cleared Hepatitis C Virus Infection 138
Glecaprevir/pibrentasvir ultra-short treatment to cure HCV infection: case report and literature review 137
Acute hepatitis B in patients with or without underlying chronic HCV infection 135
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in hepatitis C virus child-A cirrhosis 135
Ribavirin transporter [Ent1] polymorphism is a pretreatment predictor of virologic response. the specific role of donor liver transporter 128
Identification by NMR spectroscopy of urinary biomarkers of HCV cirrhosis and of systemic metabolic changes due to anti-viral HCV therapy 127
Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment 126
Fatal acute hepatitis C virus infection in patients with Hematological malignancies. 124
Corticosteroid use, myocardial injury and in-hospital cardiovascular events in patients with community-acquired pneumonia 124
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial 120
Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study 118
Retreatment of chronic hepatitis C patients non responder to a previous antiviral treatment 111
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV Child-A cirrhosis 110
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 107
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 105
Short-and long-term immunological responses in chronic HCV/HIV co-infected compared to HCV mono-infected patients after DAA therapy 99
Precision medicine. Determination of ribavirin urinary metabolites in relation to drug adverse effects in HCV patients 91
Coinvolgimento glomerulare e tubulare in pazienti con cirrosi epatica HCV relata 90
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 86
Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C 82
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 82
Serum Bactericidal Activity Levels Monitor to Guide Intravenous Dalbavancin Chronic Suppressive Therapy of Inoperable Staphylococcal Prosthetic Valve Endocarditis: A Case Report 80
RIBAVIRIN PRIMING IMPROVES THE SUSTAINED VIROLOGICAL RESPONSE TO ANTIVIRAL THERAPY IN TRANSPLANTED PATIENS WITH RECURRENT HEPATITS C 75
null 61
null 56
null 51
Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study 49
Low prevalence of Hcv infection among Msm in an intervention for Hcv micro-elimination in Rome urges a focus on high-risk behaviours 44
null 43
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease 39
null 37
null 24
A Single-Center Retrospective Study on Early Treatment for COVID-19 in Solid Organ Transplant Recipients During the Omicron Era: Outcomes and SARS-CoV-2 Viral Kinetics 19
null 4
Totale 6.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.488
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022562 15 30 45 38 59 22 14 53 48 26 131 81
2022/2023692 98 145 64 95 104 64 6 37 55 4 12 8
2023/2024255 22 33 15 24 39 31 7 24 0 29 17 14
2024/20251.145 22 129 42 49 29 89 48 39 175 92 96 335
2025/20262.399 269 74 197 186 313 137 391 111 219 286 126 90
Totale 6.828